the Effect of Exercise and Oral Supplement Intervention in Sarcopenia Markers in Hemodialysis Patients
NCT ID: NCT05809219
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2023-07-10
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period.
Setting \& Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria.
Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement in 1 to 2 hours after exercise program. Group B: Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Exercise and Protein Supplementation on Muscle Function in Patients With Hemodialysis
NCT04927208
Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone
NCT01057680
Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia
NCT02374268
Nutrition and Exercise for Sarcopenia
NCT00872911
Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia
NCT00748696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Participants maintain usual diet and physical activity without any intervention
No interventions assigned to this group
1 hour combined intervention ( Exercise and nutrition)
During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement (103 kcal and 8.4 g of protein) in 1 to 2 hours after exercise program.
1 hour combined intervention ( Exercise and nutrition)
Subjects take oral supplement after exercise in the time period between 1-2 hours. They will take oral supplement during hemodialysis treatment.
3 hours combined intervention ( Exercise and nutrition)
The only one different between "1 hour combined intervention" and this intervention is the time interval between exercise and nutrition. The time interval of "1 hour combined intervention" is 1 to 2 hour, and this intervention is 2.5-4 hours. Other procedure is totally the same.
3 hours combined intervention ( Exercise and nutrition)
All procedures between "1 hour combined intervention" and "3 hours combined intervention" are the same. The only one different is the time interval between exercise and nutrition. In this arm, the time interval of exercise and nutrition is 2.5 to 4 hours. When we recruiting subjects, all interventions will be clearly introduced to them, including the same and the different parts among them.
Nutrition intervention
Participants only take oral supplement. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".
Nutrition intervention
Subjects only take oral supplement during hemodialysis treatment. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1 hour combined intervention ( Exercise and nutrition)
Subjects take oral supplement after exercise in the time period between 1-2 hours. They will take oral supplement during hemodialysis treatment.
3 hours combined intervention ( Exercise and nutrition)
All procedures between "1 hour combined intervention" and "3 hours combined intervention" are the same. The only one different is the time interval between exercise and nutrition. In this arm, the time interval of exercise and nutrition is 2.5 to 4 hours. When we recruiting subjects, all interventions will be clearly introduced to them, including the same and the different parts among them.
Nutrition intervention
Subjects only take oral supplement during hemodialysis treatment. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemodialysis treatment 3 times treatment per weeks
* Kt/V≥1.2 or URR≥65%
* Taking foods by oral
* Meeting the criteria of sarcopenia.
Exclusion Criteria
* Amputation
* Significantly edema
* Receiving palliative care
* Severe angina
* Unstable arrhythmias
* Severe infection
* Heart failure (class 4 of New York Heart Association scale)
* Central venous catheter or femoral arteriovenous fistula
* Pacemaker
* Pregnancy
* Severe paleness
* Severe difficulty breathing
* Chest pain
* Hospitalization 3 months before recruited in this study
* Oral supplement intolerance diagnosed by the doctor or dietitian
* Bone injury/nerve damage/cognition impairment affecting physical activity intervention
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pei-Yu Wu
Project Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PEIYU WU
Role: PRINCIPAL_INVESTIGATOR
Project Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University Hospital
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSTC 112-2320-B-039-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.